Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor

Christopher J. Magovern, Charles A. Mack, John Zhang, Todd K. Rosengart, O. Wayne Isom, Ronald Crystal

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The feasibility of a single administration of a replication-deficient adenovirus (Ad) vector encoding the cDNA for human vascular endothelial growth factor (VEGF) (AdCMV.VEGF) to induce neovascularization in vivo in normal tissue was evaluated in retroperitoneal adipose tissue. Following administration of AdCMV.VEGF (109 pfu/50 μl), maximal VEGF cDNA expression was observed at 2-5 days in the injected adipose tissue. No VEGF protein was detected at ≤ 10 days in injected adipose tissue, and there was no increase in serum VEGF levels at any time. In vivo quantification of the number of blood vessels using 30x visualization of the adipose tissue demonstrated an increase in vessel number by 10 days, plateauing by 30 days with a 123% increase in vessel number compared to the control vector AdCMV.Null, despite the fact that no VEGF protein was detected after 5 days. Consistent with the in vivo data, histologic quantification of capillary number demonstrated an increase by day 5, reaching a 38% increase over AdCMV.Null by day 30. These observations demonstrate that an Ad vector carrying the VEGF cDNA is capable of inducing the growth of new blood vessels in a regional fashion in a relatively avascular, normal organ. This suggests in vivo Ad-mediated gene transfer may be useful for therapeutic angiogenesis in the treatment of ischemic cardiovascular disease.

Original languageEnglish
Pages (from-to)215-227
Number of pages13
JournalHuman Gene Therapy
Volume8
Issue number2
DOIs
Publication statusPublished - 20 Jan 1997
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor A
Adenoviridae
Adipose Tissue
Complementary DNA
Blood Vessels
Intra-Abdominal Fat
Proteins
Cardiovascular Diseases
Growth
Serum
Genes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. / Magovern, Christopher J.; Mack, Charles A.; Zhang, John; Rosengart, Todd K.; Isom, O. Wayne; Crystal, Ronald.

In: Human Gene Therapy, Vol. 8, No. 2, 20.01.1997, p. 215-227.

Research output: Contribution to journalArticle

Magovern, Christopher J. ; Mack, Charles A. ; Zhang, John ; Rosengart, Todd K. ; Isom, O. Wayne ; Crystal, Ronald. / Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. In: Human Gene Therapy. 1997 ; Vol. 8, No. 2. pp. 215-227.
@article{a44e7ac070554cdba064e4a0bef9807e,
title = "Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor",
abstract = "The feasibility of a single administration of a replication-deficient adenovirus (Ad) vector encoding the cDNA for human vascular endothelial growth factor (VEGF) (AdCMV.VEGF) to induce neovascularization in vivo in normal tissue was evaluated in retroperitoneal adipose tissue. Following administration of AdCMV.VEGF (109 pfu/50 μl), maximal VEGF cDNA expression was observed at 2-5 days in the injected adipose tissue. No VEGF protein was detected at ≤ 10 days in injected adipose tissue, and there was no increase in serum VEGF levels at any time. In vivo quantification of the number of blood vessels using 30x visualization of the adipose tissue demonstrated an increase in vessel number by 10 days, plateauing by 30 days with a 123{\%} increase in vessel number compared to the control vector AdCMV.Null, despite the fact that no VEGF protein was detected after 5 days. Consistent with the in vivo data, histologic quantification of capillary number demonstrated an increase by day 5, reaching a 38{\%} increase over AdCMV.Null by day 30. These observations demonstrate that an Ad vector carrying the VEGF cDNA is capable of inducing the growth of new blood vessels in a regional fashion in a relatively avascular, normal organ. This suggests in vivo Ad-mediated gene transfer may be useful for therapeutic angiogenesis in the treatment of ischemic cardiovascular disease.",
author = "Magovern, {Christopher J.} and Mack, {Charles A.} and John Zhang and Rosengart, {Todd K.} and Isom, {O. Wayne} and Ronald Crystal",
year = "1997",
month = "1",
day = "20",
doi = "10.1089/hum.1997.8.2-215",
language = "English",
volume = "8",
pages = "215--227",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor

AU - Magovern, Christopher J.

AU - Mack, Charles A.

AU - Zhang, John

AU - Rosengart, Todd K.

AU - Isom, O. Wayne

AU - Crystal, Ronald

PY - 1997/1/20

Y1 - 1997/1/20

N2 - The feasibility of a single administration of a replication-deficient adenovirus (Ad) vector encoding the cDNA for human vascular endothelial growth factor (VEGF) (AdCMV.VEGF) to induce neovascularization in vivo in normal tissue was evaluated in retroperitoneal adipose tissue. Following administration of AdCMV.VEGF (109 pfu/50 μl), maximal VEGF cDNA expression was observed at 2-5 days in the injected adipose tissue. No VEGF protein was detected at ≤ 10 days in injected adipose tissue, and there was no increase in serum VEGF levels at any time. In vivo quantification of the number of blood vessels using 30x visualization of the adipose tissue demonstrated an increase in vessel number by 10 days, plateauing by 30 days with a 123% increase in vessel number compared to the control vector AdCMV.Null, despite the fact that no VEGF protein was detected after 5 days. Consistent with the in vivo data, histologic quantification of capillary number demonstrated an increase by day 5, reaching a 38% increase over AdCMV.Null by day 30. These observations demonstrate that an Ad vector carrying the VEGF cDNA is capable of inducing the growth of new blood vessels in a regional fashion in a relatively avascular, normal organ. This suggests in vivo Ad-mediated gene transfer may be useful for therapeutic angiogenesis in the treatment of ischemic cardiovascular disease.

AB - The feasibility of a single administration of a replication-deficient adenovirus (Ad) vector encoding the cDNA for human vascular endothelial growth factor (VEGF) (AdCMV.VEGF) to induce neovascularization in vivo in normal tissue was evaluated in retroperitoneal adipose tissue. Following administration of AdCMV.VEGF (109 pfu/50 μl), maximal VEGF cDNA expression was observed at 2-5 days in the injected adipose tissue. No VEGF protein was detected at ≤ 10 days in injected adipose tissue, and there was no increase in serum VEGF levels at any time. In vivo quantification of the number of blood vessels using 30x visualization of the adipose tissue demonstrated an increase in vessel number by 10 days, plateauing by 30 days with a 123% increase in vessel number compared to the control vector AdCMV.Null, despite the fact that no VEGF protein was detected after 5 days. Consistent with the in vivo data, histologic quantification of capillary number demonstrated an increase by day 5, reaching a 38% increase over AdCMV.Null by day 30. These observations demonstrate that an Ad vector carrying the VEGF cDNA is capable of inducing the growth of new blood vessels in a regional fashion in a relatively avascular, normal organ. This suggests in vivo Ad-mediated gene transfer may be useful for therapeutic angiogenesis in the treatment of ischemic cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=0031039505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031039505&partnerID=8YFLogxK

U2 - 10.1089/hum.1997.8.2-215

DO - 10.1089/hum.1997.8.2-215

M3 - Article

C2 - 9017425

AN - SCOPUS:0031039505

VL - 8

SP - 215

EP - 227

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 2

ER -